As of 2024-12-12, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (66.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -80469.2%.
The range of the Relative Valuation is (62.45) - (58.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (62.45) - (58.28) | (66.71) |
| Upside | -75343.7% - -70322.8% | -80469.2% |
| Date | P/E |